Source: PE HUB

CorrectChemo: DiaTech rakes in $75 mln

Franklin, Tennessee-based DiaTech, which helps oncologists determine cancer treatments for patients, has secured $75 million in financing. The backer is Keyholder Investments. Also, DiaTech has named Dr. Ronald Krall, Daniel Tasse, and Dr. Lawrence Van Horn to its board.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Robert E. Henry's photo - President & CEO of CorrectChemo

President & CEO

Robert E. Henry

CEO Approval Rating

70/100

Read more